Aytu Biopharma Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$2.27

+0.02 (+0.89%)

As of Jun 23, 5:30 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +303.1% upside

Low Target $5.34

Average Target $9.15

High Target $10.98

Current Price $2.27

Current
$2.27

Target
$9.15

$5.34 $9.15 avg $10.98

Scenario Analysis

Bear Case

$5.34

135.2%

Low target

Base Case

$9.15

+303.1%

Avg target

Bull Case

$10.98

+383.7%

High target

Risk/Reward

2.8x

Favorable

Price in Context

52-Week High

$3.07

-25.9% from high

52-Week Low

$1.65

+37.6% from low

Target vs 52W High

$9.15

+198.5% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	79%	$1,330.33	+20.2%
RDY Dr. Reddy's Laboratories	Sell	44	50%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+25.3%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+33.2%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+37.1%
BMY Bristol-Myers Squibb Co	Hold	36	39%	$174.50	+214.2%
ZTS Zoetis Inc	Buy	24	58%	$209.87	+173.1%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-34.5%